People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kadmon Holdings, LLC | — | Biotechnology | Series A | $10.4M | $205.7M | 2012 |
Financial D John Thomas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Financial D John Thomas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven N Gordon | 1 | 3 |
| Samuel D Waksal | 1 | 3 |
| Susan D Wiviott | 1 | 1 |
| Larry D Witte | 1 | 1 |
| Eugene D Bauer | 1 | 1 |
| Zhenping D Zhu | 1 | 1 |
| Alexandria D Forbes | 1 | 1 |
| Dixon D Boardman | 1 | 1 |
| Richard D Mulligan | 1 | 1 |
| Adriann D Sax | 1 | 1 |
| David D Blaustein | 1 | 1 |
| Thomas D Shenk | 1 | 1 |
| Harlan D Waksal | 1 | 1 |
| John D Ryan | 1 | 1 |
| Louis Shengda D Zan | 1 | 1 |
| Andrew D Cohen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.